Home > News > Labopharm reports results for second quarter fiscal 2004
July 28th, 2004
Labopharm reports results for second quarter fiscal 2004
Labopharm Inc. (TSX: DDS) today reported its results for the second quarter of fiscal 2004 ended June 30, 2004. Net loss for the second quarter of fiscal 2004 was $7.1 million, or $0.18 per share, compared with $8.8 million, or $0.28 per share, for the second quarter of fiscal 2003.
Graphenea sales more than double in 2014 January 29th, 2015
Nanometrics to Announce Fourth Quarter and Full Year Financial Results on February 2, 2015 January 7th, 2015
Harris & Harris Group Reports Financial Statements as of September 30, 2014 November 11th, 2014
Harris & Harris Group to Host Conference Call on Third Quarter 2014 Financial Results on November 12, 2014 November 3rd, 2014